MRNA expression profiles of P450 3A enzymes in the liver and small intestine of the domestic pig

Research in Veterinary Science

Volumn 93, Issue 1, 2012, Pages 360-365

  Yao, Min ^a   Dai, Menghong ^a   Liu, Zhaoying ^a   Cui, Wenlong ^a   Li, Daoyuan ^a   Zhang, Huahai ^a   Li, Juan ^a   Liu, Yahui ^a   Yuan, Zonghui ^a  

^a HUAZHONG AGRICULTURAL UNIVERSITY   (China)

Author keywords

Cytochrome P450 3A; Expression; Liver; Pig; Small intestine

Indexed keywords

CYTOCHROME P450 3A; CYTOCHROME P450 3A22; CYTOCHROME P450 3A29; CYTOCHROME P450 3A39; CYTOCHROME P450 3A46; MESSENGER RNA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOMESTIC PIG; DUODENUM; GENE EXPRESSION PROFILING; ILEUM; LIVER; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SMALL INTESTINE; XENOBIOTIC METABOLISM;

ANIMALS; CYTOCHROME P-450 CYP3A; DUODENUM; GENE EXPRESSION; ILEUM; INTESTINE, SMALL; JEJUNUM; LIVER; MALE; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER; SWINE;

MAMMALIA; SUIDAE; SUS; SUS SCROFA DOMESTICA;

EID: 84861480924     PISSN: 00345288     EISSN: 15322661     Source Type: Journal    
DOI: 10.1016/j.rvsc.2011.06.013     Document Type: Article

References (36)

1. Anzenbacherova E., Baranova J., Zuber R., Pechova A., Anzenbacher P., Soucek P., Martinkova J. Model systems based on experimental animals for studies on drug metabolism in man: (mini)pig cytochromes P450 3A29 and 2E1. Basic & Clinical Pharmacology & Toxicology 2005, 96:244-245.
2. Bieche I., Narjoz C., Asselah T., Vacher S., Marcellin P., Lidereau R., Beaune P., de Waziers I. Reverse transcriptase-PCR quantification of mRNA levels from cytochrome (CYP)1, CYP2 and CYP3 families in 22 different human tissues. Pharmacogenetics and Genomics 2007, 17:731-742.
3. de Waziers I., Cugnenc P.H., Yang C.S., Leroux J.P., Beaune P.H. Cytochrome P 450 isoenzymes, epoxide hydrolase and glutathione transferases in rat and human hepatic and extrahepatic tissues. Journal of Pharmacology and Experimental Therapeutics 1990, 253:387-394.
4. Fink-Gremmels J. Implications of hepatic cytochrome P450-related biotransformation processes in veterinary sciences. European Journal of Pharmacology 2008, 585:502-509.
5. Hansen T., Borlak J., Bader A. Cytochrome P450 enzyme activity and protein expression in primary porcine enterocyte and hepatocyte cultures. Xenobiotica 2000, 30:27-46.
6. Hosagrahara V.P., Hansen L.K., Remmel R.P. Induction of the metabolism of midazolam by rifampin in cultured porcine hepatocytes: preliminary evidence for CYP3A isoforms in pigs. Drug Metabolism and Disposition 1999, 27:1512-1518.
7. Ioannides C. Cytochrome p450 expression in the liver of food-producing animals. Current Drug Metabolism 2006, 7:335-348.
8. Koch I., Weil R., Wolbold R., Brockmoller J., Hustert E., Burk O., Nuessler A., Neuhaus P., Eichelbaum M., Zanger U., Wojnowski L. Interindividual variability and tissue-specificity in the expression of cytochrome P450 3A mRNA. Drug Metabolism and Disposition 2002, 30:1108-1114.
9. Kolars J.C., Lown K.S., Schmiedlin-Ren P., Ghosh M., Fang C., Wrighton S.A., Merion R.M., Watkins P.B. CYP3A gene expression in human gut epithelium. Pharmacogenetics 1994, 4:247-259.
10. Lamba J.K., Lin Y.S., Schuetz E.G., Thummel K.E. Genetic contribution to variable human CYP3A-mediated metabolism. Advanced Drug Delivery Reviews 2002, 54:1271-1294.
11. Lin Y.S., Dowling A.L., Quigley S.D., Farin F.M., Zhang J., Lamba J., Schuetz E.G., Thummel K.E. Co-regulation of CYP3A4 and CYP3A5 and contribution to hepatic and intestinal midazolam metabolism. Molecular Pharmacology 2002, 62:162-172.
12. Mate L., Virkel G., Lifschitz A., Sallovitz J., Ballent M., Lanusse C. Phase 1 and phase 2 metabolic activities along the small intestine in adult male sheep. Journal of Veterinary Pharmacology and Therapeutics 2010, 33:537-545.
13. McKinnon R.A., Burgess W.M., Hall P.M., Roberts-Thomson S.J., Gonzalez F.J., McManus M.E. Characterisation of CYP3A gene subfamily expression in human gastrointestinal tissues. Gut 1995, 36:259-267.
14. Mealey K.L., Jabbes M., Spencer E., Akey J.M. Differential expression of CYP3A12 and CYP3A26 mRNAs in canine liver and intestine. Xenobiotica 2008, 38:1305-1312.
15. Messina A., Nannelli A., Fiorio R., Longo V., Gervasi P.G. Expression and inducibility of CYP1A1, 1A2, 1B1 by beta-naphthoflavone and CYP2B22, 3A22, 3A29, 3A46 by rifampicin in the respiratory and olfactory mucosa of pig. Toxicology 2009, 260:47-52.
16. Mitschke D., Reichel A., Fricker G., Moenning U. Characterization of cytochrome P450 protein expression along the entire length of the intestine of male and female rats. Drug Metabolism and Disposition 2008, 36:1039-1045.
17. Myers M.J., Farrell D.E., Howard K.D., Kawalek J.C. Identification of multiple constitutive and inducible hepatic cytochrome P450 enzymes in market weight swine. Drug Metabolism and Disposition 2001, 29:908-915.
18. Nannelli A., Chirulli V., Longo V., Gervasi P.G. Expression and induction by rifampicin of CAR- and PXR-regulated CYP2B and CYP3A in liver, kidney and airways of pig. Toxicology 2008, 252:105-112.
19. Nishi K., Ishii T., Wada M., Amae S., Sano N., Nio M., Hayashi Y. The expression of intestinal CYP3A4 in the piglet model. Transplantation Proceedings 2004, 36:361-363.
20. Paine M.F., Khalighi M., Fisher J.M., Shen D.D., Kunze K.L., Marsh C.L., Perkins J.D., Thummel K.E. Characterization of interintestinal and intraintestinal variations in human CYP3A-dependent metabolism. Journal of Pharmacology and Experimental Therapeutics 1997, 283:1552-1562.
21. Phillips A., Hood S.R., Gibson G.G., Plant N.J. Impact of transcription factor profile and chromatin conformation on human hepatocyte CYP3A gene expression. Drug Metabolism and Disposition 2005, 33:233-242.
22. Puccinelli E., Gervasi P.G., La Marca M., Beffy P., Longo V. Expression and inducibility by phenobarbital of CYP2C33, CYP2C42, CYP2C49, CYP2B22, and CYP3As in porcine liver, kidney, small intestine, and nasal tissues. Xenobiotica 2010, 40:525-535.
23. Richert L., Tuschl G., Abadie C., Blanchard N., Pekthong D., Mantion G., Weber J.C., Mueller S.O. Use of mRNA expression to detect the induction of drug metabolising enzymes in rat and human hepatocytes. Toxicology and Applied Pharmacology 2009, 235:86-96.
24. Schuetz E.G., Schuetz J.D., Strom S.C., Thompson M.T., Fisher R.A., Molowa D.T., Li D., Guzelian P.S. Regulation of human liver cytochromes P-450 in family 3A in primary and continuous culture of human hepatocytes. Hepatology 1993, 18:1254-1262.
25. Shang H., Yang J., Liu Y., Wei H. Tissue distribution of CYP3A29 mRNA expression in Bama miniature pig by quantitative reverse transcriptase-polymerase chain reaction (RT-PCR). Xenobiotica 2009, 39:423-429.
26. Shen D.D., Kunze K.L., Thummel K.E. Enzyme-catalyzed processes of first-pass hepatic and intestinal drug extraction. Advanced Drug Delivery Reviews 1997, 27:99-127.
27. Skaanild M.T. Porcine cytochrome P450 and metabolism. Current Pharmaceutical Design 2006, 12:1421-1427.
28. Skaanild M.T., Friis C. Analyses of CYP2C in porcine microsomes. Basic and Clinical Pharmacology and Toxicology 2008, 103:487-492.
29. Szotakova B., Baliharova V., Lamka J., Nozinova E., Wsol V., Velik J., Machala M., Neca J., Soucek P., Susova S., Skalova L. Comparison of in vitro activities of biotransformation enzymes in pig, cattle, goat and sheep. Research in Veterinary Science 2004, 76:43-51.
30. Telhada M.B., Pereira T.M., Lechner M.C. Effect of dexamethasone and phenobarbital on run-on transcription rate and CYP3A mRNA concentration in rat liver: changes during development. Archives of Biochemistry and Biophysics 1992, 298:715-725.
31. Thelen K., Dressman J.B. Cytochrome P450-mediated metabolism in the human gut wall. Journal of Pharmacy and Pharmacology 2009, 61:541-558.
32. Virkel G., Carletti M., Cantiello M., Della Donna L., Gardini G., Girolami F., Nebbia C. Characterization of xenobiotic metabolizing enzymes in bovine small intestinal mucosa. Journal of Veterinary Pharmacology and Therapeutics 2009, 33:295-303.
33. Wrighton S.A., Stevens J.C. The human hepatic cytochromes P450 involved in drug metabolism. Critical Reviews in Toxicology 1992, 22:1-21.
34. Xiaohu Ge, Junping Wang, Jing Liu, Jun Jiang, Huina Lin, Jun Wu, Man Ouyang, Xianqing Tang, Ming Zheng, Ming Liao, Yiqun Deng The catalytic activity of cytochrome P450 3A22 is critical for the metabolism of T-2 toxin in porcine reservoirs. Catalysis Communications 2010, 12:71-75.
35. Yao M., Dai M., Liu Z., Huang L., Chen D., Wang Y., Peng D., Wang X., Liu Z., Yuan Z. Comparison of the substrate kinetics of pig CYP3A29 with pig liver microsomes and human CYP3A4. Bioscience Reports 2011, 31:211-220.
36. Zuber R., Anzenbacherova E., Anzenbacher P. Cytochromes P450 and experimental models of drug metabolism. Journal of Cellular and Molecular Medicine 2002, 6:189-198.